The start-up Seekyo, specializing in the development of smart chemotherapy drugs and whose scientific director and co-founder is Sébastien Papot (Poitiers) has raised more than € 650,000 from business angels and Bpifrance.
Bridge financing will enable company to strengthen preclinical data for its main drug candidate SKY01, targeting solid tumors, and to set foundations for regulatory review.
